Kenya Promotes Gender-Sensitive Drug Policies at International Forum

Kenya advocates for gender-sensitive drug policies, emphasizing inclusive approaches during the 2025 Commission on Narcotic Drugs meeting in Vienna. Dr. Stephen Mairori highlighted the need for gender-responsive measures, acknowledging the more severe impact of substance abuse on women. The revised National Drug Control Policy aims to enhance treatment accessibility, including free rehabilitation services for women in Mombasa. Collaboration among stakeholders is essential for effective program implementation.

Kenya has reaffirmed its dedication to incorporating gender-sensitive approaches into drug policies, aiming for inclusive interventions that address the unique challenges faced by both men and women. Speaking at a side event of the 2025 Commission on Narcotic Drugs meeting in Vienna, Dr. Stephen Mairori, Board Chair and Head of the Kenyan Delegation, underscored the significance of gender-responsive drug control measures.

Dr. Mairori highlighted the differences in drug use patterns, pointing out that, while men have higher rates of drug consumption, the consequences are often more severe for women. He emphasized the need for rehabilitation frameworks to adapt to these gender distinctions to improve accessibility and effectiveness.

He advocated for targeted interventions, including the establishment of women-only rehabilitation centers that address specific concerns such as pregnancy, childcare, and safety. Kenya has proactively revised its National Drug Control Policy to incorporate gender-sensitive strategies, recognizing the barriers women face in accessing treatment and proposing solutions to alleviate these challenges.

Dr. Mairori announced the introduction of free rehabilitation services for women at the Miritini Drug Rehabilitation Centre in Mombasa. This initiative aims to increase participation in treatment programs by removing financial obstacles, alongside collaborative efforts with county governments to implement gender-specific prevention, rehabilitation, and reintegration methods.

Emphasizing the need for ongoing dialogue among policymakers, researchers, and implementers, Dr. Mairori urged countries to adhere to international guidelines on gender-sensitive drug policies. He called for strengthened partnerships to enhance the effectiveness of drug-related programs as a means to ensure no gender is overlooked in drug control efforts.

This session, co-sponsored by the United Nations Office on Drugs and Crime and the Norwegian government, provided a forum for experts to explore solutions for gender disparities within drug policies. Dr. Mairori concluded by urging participants to foster collaboration and create policies that genuinely meet the diverse needs of all affected by substance abuse.

In conclusion, Kenya’s advocacy for gender-sensitive drug policies emphasizes the need for inclusive approaches that address the unique challenges experienced by men and women in substance abuse contexts. The initiative’s focus on providing targeted rehabilitation services, while fostering dialogue among stakeholders, showcases Kenya’s commitment to addressing gender disparities in drug control effectively. By reinforcing global cooperative efforts, Kenya is positioning itself as a leader in promoting inclusive drug policies.

Original Source: www.capitalfm.co.ke